Guinea-Bissau vs Turkmenistan: Treatment success rate for patients treated for MDR-TB
Guinea-Bissau
71.0%
in 2022
Turkmenistan
71.0%
in 2022
Guinea-Bissau rank
91st
Turkmenistan rank
91st
Treatment success rate for patients treated for MDR-TB over time
- Guinea-Bissau
- Turkmenistan
How they compare
Guinea-Bissau currently reports 71.0% against 71.0% in Turkmenistan, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2013 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 91st and Turkmenistan ranks 91st of 163 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.1% | 50.7% | 5.6% | Turkmenistan |
| 2020s | 40.3% | 67.3% | 27.0% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Guinea-Bissau or Turkmenistan?
- Guinea-Bissau, at 71.0% against 71.0% in Turkmenistan as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Guinea-Bissau and Turkmenistan?
- 0.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Turkmenistan?
- 10 years are reported by both, from 2013 to 2022.
- How do Guinea-Bissau and Turkmenistan rank globally for treatment success rate for patients treated for mdr-tb?
- Guinea-Bissau ranks 91st and Turkmenistan ranks 91st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.